Advancing the Exploration of Quantum-Accelerated Applications in Drug Design
Join ID Quantique and ORCA Computing for the latest in our series of Quantum Detection Systems webinars.
Date: Thursday, April 24th 2025
Time: 4pm CET (10am EDT)
Duration: 45 minutes
Register Now
Abstract
The pursuit of quantum-accelerated drug design requires precise control over photon dynamics to meet the increasing demands for computational power and scalability.
In this joint webinar, ORCA Computing and IDQ will discuss their collaborative efforts to push the boundaries of quantum computing in pharmaceutical research. They will introduce the PT-2, the latest advancement in ORCA's PT Series of photonic quantum systems, delivering quantum-accelerated generative AI capabilities. Integrated within this system is IDQ’s ID281 Pro, a superconducting nanowire detector that enhances multi-photon sampling efficiency, reducing loss and boosting fidelity.
Industry leaders from both organizations will explore the challenges of quantum-enhanced drug discovery, explain how their technologies integrate and discuss the PT-2 system’s capabilities. Attendees will gain insights into real-world applications and the next steps for quantum computing in pharmaceuticals.
Speakers
Dr. Thien-An Nguyen, CTO at ORCA Computing
Dr. Félix Bussières, VP of Product & Technology, Quantum Detection Systems at IDQ
Moderator : Juliet Mc Ginnis, Communication Lead at ORCA Computing
Agenda
- Setting the Stage: Quantum’s Role in Drug Design
- Joint Collaboration: ORCA Computing and IDQ
- Introduction to ORCA’s PT-2 System
- IDQ’s ID281 Pro SNSPD System: Advancing Multi-Photon Detection
- Use Case: Quantum-Enhanced Drug Design
- Q&A Session
